Richard J. Barohn

Active 1988–2024

Also published as
Richard J Barohn
148
Papers
29,223
Citations
98
h-index
142
i10-index

Citations

Citations per year for Richard J. Barohn1951: 3 citations1989: 1 citations1990: 5 citations1991: 11 citations1992: 4 citations1993: 9 citations1994: 12 citations1995: 10 citations1996: 33 citations1997: 30 citations1998: 27 citations1999: 41 citations2000: 46 citations2001: 76 citations2002: 103 citations2003: 110 citations2004: 81 citations2005: 136 citations2006: 108 citations2007: 120 citations2008: 156 citations2009: 150 citations2010: 179 citations2011: 155 citations2012: 145 citations2013: 143 citations2014: 132 citations2015: 167 citations2016: 185 citations2017: 176 citations2018: 233 citations2019: 812 citations2020: 941 citations2021: 830 citations2022: 725 citations2023: 543 citations2024: 934 citations2025: 338 citations2026: 9 citations1952–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,294 citing papers, 25.6% of this breakdownUnited Kingdom: 823 citing papers, 9.2% of this breakdownItaly: 627 citing papers, 7% of this breakdownGermany: 542 citing papers, 6.1% of this breakdownFrance: 481 citing papers, 5.4% of this breakdownChina: 446 citing papers, 5% of this breakdownCanada: 398 citing papers, 4.4% of this breakdownNetherlands: 370 citing papers, 4.1% of this breakdownJapan: 320 citing papers, 3.6% of this breakdownAustralia: 236 citing papers, 2.6% of this breakdownSpain: 225 citing papers, 2.5% of this breakdownBelgium: 191 citing papers, 2.1% of this breakdown
0%25.6%Other 22.4%

Fields

  • Medicine74.7%
  • Biochemistry, Genetics and Molecular Biology16.9%
  • Neuroscience4.3%
  • Immunology and Microbiology2.7%
  • Engineering0.2%
  • Nursing0.2%
  • Other1%

Topics

  • Myasthenia Gravis and Thymoma6.4%
  • Peripheral Neuropathies and Disorders6.2%
  • Inflammatory Myopathies and Dermatomyositis5.4%
  • Amyotrophic Lateral Sclerosis Research4.8%
  • Muscle Physiology and Disorders4%
  • Neurogenetic and Muscular Disorders Research4%
  • Other69.2%

Coauthors

All papers

Open in search
  1. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julia Wanschitz, Wolfgang N. Löscher, Jan De Bleecker, Guy Van den Abeele, Kathy de Koning, Katrien De Mey, Rudy Mercelis, Linda Wagemaekers, Délphine Mahieu, Philip Van Damme, Charlotte Smetcoren, Olivier Stevens, Sarah Verjans, Ann D’Hondt, Petra Tilkin, Alzira Alves de Siqueira Carvalho, Rosa Hasan, Igor Dias Brockhausen, David Feder, Daniel Ambrosio, Ana Paula Souto Melo, Rosana Rocha, Bruno Bezerra Rosa, Thabata Veiga, Luiz Augusto da Silva, Jordana Gonçalves Geraldo, Maria da Penha Morita Ananias, Érica Nogueira Coelho, Gabriel Pina Paiva, M Tovar Pozo, Natália Prando, Debora Dada Martineli Torres, Cristiani Fernanda Butinhao, Érica Nogueira Coelho, Luciana Renata Cubas Volpe, Gustavo Duran, Tamires Cristina Gomes da Silva, Luiz Otavio Maia Gonçalves, Lucas Eduardo Pazetto, Luciana Souza Duca, Tomás Augusto Suriane Fialho, Maurício Friedrich, Alexandre Guerreiro, Henrique Mohr, Maurer Pereira Martins, Daiane da Cruz Pacheco, Ana Paula Macagnan, Aline de Cassia Santos, Acary Souza Bullé Oliveira, Ana Carolina Amaral de Andrade, Marcelo Annes, Valéria Cavalcante Lino, Wladimir Bocca Vieira de Rezende Pinto, Carolina Miranda, Fernanda Carrara, Iandra Souza, Angela Genge, Rami Massie, Natasha Campbell, Vera Bril, Hans Katzberg, Mehran Soltani, Eduardo Ng, Zaeem A. Siddiqi, Celile Phan, Derrick Blackmore, Stanislav Voháňka, Josef Bednařík, Magda Chmelikova, Marek Čierny and 524 more - The Lancet Neurology 2017 cited by 800

  2. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helga Sanner, Albert Selva-O’Callaghan, Yeong‐Wook Song, Jiří Vencovský, Steven R. Ytterberg, Frederick W. Miller, Lisa G. Rider - Annals of the Rheumatic Diseases 2017 cited by 1,525

  3. Myasthenia gravis

    Authors: , , , , , , - Neurology 2000 cited by 1,621

  4. Myasthenia gravis activities of daily living profile

    Authors: , , , , , - Neurology 1999 cited by 544

  5. Randomized Trial of Thymectomy in Myasthenia Gravis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael H. Rivner, Anna Kostera‐Pruszczyk, Robert M. Pascuzzi, Carlayne E. Jackson, Guillermo Ramos, Jan J.G.M. Verschuuren, Janice M. Massey, John T. Kissel, Lineu César Werneck, Michael Benatar, Richard J. Barohn, Rup Tandan, Tahseen Mozaffar, Robin Conwit, Joanne Odenkirchen, Joshua Sonett, Alfred Jaretzki, John Newsom–Davis, Gary Cutter - New England Journal of Medicine 2016 cited by 905

  6. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo‐phase trial

    Authors: , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2012 cited by 691

  7. Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patrice L. Whitehead, Stephan Züchner, Mamatha Pasnoor, Omar Jawdat, Duaa Jabari, Constantine Farmakidis, Melanie Glenn, Mazen M. Dimachkie, Laura Herbelin, Hellen Tanui, Sherri Anderson, Michaela Walker, Tina Liu, Ayla McCally, Andrew Heim, Melissa Currence, Yolanda Harness, Jeri Sieren, Emilee Gibson, G. Garcia Gutierrez, Danielle Bussey, Rose Previte, Pamella Kittrell, Amruta Joshi, Amy Conger, Debbie Hastings, Irys Caristo, Mozhdeh Marandi, Simon Carty, J. Paul Taylor, Gang Wu, Evadnie Rampersaud, Rebecca Schüle, Marka van Blitterswijk - Neurology 2020 cited by 202

  8. Reliability Testing of the Quantitative Myasthenia Gravis Scorea

    Authors: , , , , , - Annals of the New York Academy of Sciences 1998 cited by 404

  9. Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis

    Authors: , , , , , , , , , , , , , , , , , , , , - Muscle & Nerve 2019 cited by 247

  10. Identification of genetic risk loci and prioritization of genes and pathways for myasthenia gravis: a genome-wide association study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James F. Howard, Theresa Jiwa, Henry J. Kaminski, John T. Kissel, Wilma J. Koopman, Bernadette Lipscomb, Michelangelo Maestri, Mariapaola Marino, Janice M. Massey, April McVey, Michelle M. Mezei, Srikanth Muppidi, Michael Nicolle, Joël Oger, Robert M. Pascuzzi, Mamatha Pasnoor, Alan Pestronk, Loredana Petrucci, Hannah A. Pliner, Carlo Provenzano, Alan E. Renton, Roberta Ricciardi, David P. Richman, Julie Rowin, Donald B. Sanders, Mario Sabatelli, Zaeem A. Siddiqi, Aimee Soloway, Laura Todi, Gil I. Wolfe, Charlie Wulf, Daniel B. Drachman, Bryan J. Traynor - National Academy of Sciences, Proceedings of the National Academy of Sciences 2022 cited by 132

  11. Effect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nancy L. Kuntz, Adnan Manzur, Basil T. Darras, Peter B. Kang, Leslie Morrison, Monika Krzesniak‐Swinarska, Jean K. Mah, Tiziana Mongini, Federica Ricci, Maja von der Hagen, Richard S. Finkel, Kathleen O’Reardon, Matthew Wicklund, Ashutosh Kumar, Craig M. McDonald, Jay J. Han, Nanette C. Joyce, Erik Henricson, Ulrike Schara‐Schmidt, Andrea Gangfuß, Ekkehard Wilichowski, Richard J. Barohn, Jeffrey Statland, Craig Campbell, Giuseppe Vita, Gian Luca Vita, James F. Howard, Imelda Hughes, Hugh J. McMillan, Elena Pegoraro, Luca Bello, W. Bryan Burnette, Mathula Thangarajh, Taeun Chang - JAMA 2022 cited by 123

  12. Interferon‐α/β–mediated innate immune mechanisms in dermatomyositis

    Authors: , , , , , , , , , , , - Annals of Neurology 2005 cited by 612

  13. Primary lateral sclerosis: consensus diagnostic criteria

    Authors: , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2020 cited by 244

  14. Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William David, Ali A. Habib, Veena Mathew, Tahseen Mozaffar, John L. Hinton, William L. Hewitt, Deborah Barnett, Patricia Sullivan, Doreen Ho, James F. Howard, Rebecca Traub, Manisha Chopra, Henry J. Kaminski, Radwa Aly, Elham Bayat, Mohammad Abu-Rub, Shaida Khan, Dale J. Lange, Shara Holzberg, Bhupendra Khatri, Emily Lindman, Tayo Olapo, Lisa Sershon, Robert P. Lisak, Evanthia Bernitsas, Kelly Jia, Rabia Malik, Tiffany D. Lewis-Collins, Michael Nicolle, Richard J. Nowak, Aditi Sharma, Bhaskar Roy, Joan Nye, Michael Pulley, Alan Ross Berger, Yasmeen Shabbir, Amit Sachdev, Kimberly Patterson, Zaeem A. Siddiqi, Mark Sivak, Joan Bratton, George A. Small, Anem Kohli, Mary Fetter, Tuan Vu, Lucy Lam, Brittany Harvey, Gil I. Wolfe, Nicholas J. Silvestri, Kara Patrick, Karen Zakalik, Petra W. Duda, James E. MacDougall, Ramin Farzaneh-Far, Angela Pontius, Michelle D. Hoarty - JAMA Neurology 2020 cited by 193

  15. Treatment of Myasthenia Gravis

    Authors: , , , - Neurologic Clinics 2018 cited by 238

  16. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael H. Rivner, Anna Kostera‐Pruszczyk, Robert M. Pascuzzi, Carlayne E. Jackson, Jan J.G.M. Verschuuren, Janice M. Massey, John T. Kissel, Lineu César Werneck, Michael Benatar, Richard J. Barohn, Rup Tandan, Tahseen Mozaffar, Nicholas J. Silvestri, Robin Conwit, Joshua Sonett, Alfred Jaretzki, John Newsom–Davis, Gary Cutter, Gary Cutter, Inmaculada Aban, Greg Minisman, Michelle Feese, Hui‐Chien Kuo, John Newsom–Davis, Gil I. Wolfe, Henry J. Kaminski, Alfred Jaretzki, Joshua Sonett, Claudio Mazia, Valeria Saluto, Moisés Rosenberg, Valeria Alvarez, Lisa A. Rocca Rey, John King, Helmut Butzkueven, John Goldblatt, John C. Carey, John R. Pollard, Stephen Reddel, Nicholas Handel, Brian C. McCaughan, Linda Pallot, Márcia Waddington‐Cruz, Ricardo Novis, Carlos Henrique Ribeiro Boasquevisque, Elza Dias‐Tosta, Rubens N. Morato-Fernandez, Manoel Ximenes, Lineu César Werneck, Rosana Hermínia Scola, Paulo Soltoski, Colin Chalk, Fraser Moore, David S. Mulder, Lisa Wadup, Joël Oger, Michele Mezei, Kenneth G. Evans, Theresa Jiwa, Anne Schaffar, Chris White, Cory Toth, Gary Gelfand, Susan P. Wood, Elizabeth Pringle, Jocelyn Zwicker, Donna E. Maziak, Farid M. Shamji, Sudhir Sundaresan, Andrew Seely and 247 more - The Lancet Neurology 2019 cited by 223

  17. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lindsay N. Alfano, Michelle Eagle, M. James, Linda Lowes, Anna Mayhew, Elena Mazzone, Leslie Nelson, Kristy Rose, Hoda Abdel‐Hamid, Susan Apkon, Richard J. Barohn, Enrico Bertini, Clemens Bloetzer, Lausanne Canton de Vaud, Russell J. Butterfield, B. Chabrol, Jong‐Hee Chae, Daehak-ro Jongno-gu, Giacomi Pietro Comi, Basil T. Darras, Jahannaz Dastgir, Isabelle Desguerre, Raúl G. Escobar, Erika Finanger, Michela Guglieri, Imelda Hughes, Susan T. Iannaccone, Kristi Jones, Peter Karachunski, Martin Kudr, Timothy Lotze, Jean K. Mah, Katherine D. Mathews, Yoram Nevo, Julie Parsons, Yann Péréon, Alexandra Prufer de Queiroz Campos Araújo, J. Ben Renfroe, Maria Bernadete Dutra de Resende, Monique M. Ryan, Kathryn Selby, Gihan Tennekoon, Giuseppe Vita - The Lancet 2017 cited by 455

  18. Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2021 cited by 134

  19. Randomized study of adjunctive belimumab in participants with generalized myasthenia gravis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Silvia Bonanno, Angela Campanella, Tiyonnoh Cash, Bakri Elsheikh, Vittorio Frasca, Namita Goyal, Brittany Harvey, Eugene C. Lai, Lorenzo Maggi, Brian Minton, Verónica Puertas‐Martín, Emanuela Onesti, Mamatha Pasnoor, Gulmohor Roy, Sheetal Shroff, Jason R. Thonhoff - Neurology 2018 cited by 128

  20. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2009 cited by 235

  21. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2007 cited by 642

  22. Myasthenia gravis: recommendations for clinical research standards

    Authors: , , , , , , - The Annals of Thoracic Surgery 2000 cited by 642

  23. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aziz Shaibani, Kumaraswamy Sivakumar, Namita Goyal, Madoka Mori‐Yoshimura, Satoshi Yamashita, Naoki Suzuki, Masahisa Katsuno, Kenya Murata, Hiroyuki Nodera, Ichizo Nishino, Carla D Romano, Valerie Williams, John Vissing, Lixin Zhang Auberson, Min Wu, Ana de Vera, Dimitris A. Papanicolaou, Anthony A. Amato - The Lancet Neurology 2019 cited by 133

  24. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anneke van der Kooi, Yves Allenbach, Matthew Appleby, Richard J Barohn, Nicolas Champtiaux, Christopher Doughty, Jerrica Farias, Constantine Farmakidis, Ali A. Habib, Chafic Karam, James Lilleker, Samantha Lorusso, Mamatha Pasnoor, Iago Pinal-Fernandez, Giorgia Querin, Joost Raaphorst, George Ransley, Sami Saba, Kazim Sheikh, Andrew Snedden, Jeffrey Statland, Tuan Vu - The Lancet Rheumatology 2023 cited by 55